Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
7.22 USD | -4.12% | -4.38% | -10.37% |
May. 09 | Cantor Fitzgerald Adjusts LifeMD's Price Target to $15 From $13, Keeps Overweight Rating | MT |
May. 08 | LifeMD, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-10.37% | 318M | |
-10.27% | 27.7B | |
+22.59% | 8.46B | |
+27.15% | 4.3B | |
-35.54% | 2.41B | |
-7.53% | 1.62B | |
-16.58% | 1.45B | |
-32.60% | 1.16B | |
+1.74% | 919M | |
-40.61% | 830M |
- Stock Market
- Equities
- LFMD Stock
- News LifeMD, Inc.
- B. Riley Lowers LifeMD's Price Target to $8 from $16, Notes Slower-than-Anticipated Start in Q1 Impacted by Technology Upgrades, Integrations; Keeps Buy Rating